SHP.L : Summary for SHIRE PLC ORD 5P - Yahoo Finance

U.S. Markets closed

Shire plc (SHP.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
4,676.50+11.50 (+0.25%)
At close: 5:11PM GMT
People also watch
SN.LWPP.LAZN.LSDR.LSMIN.L
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4,665.00
Open4,651.00
Bid4,611.00 x 51000
Ask4,800.00 x 53800
Day's Range4,643.50 - 4,714.00
52 Week Range2,707.19 - 5,377.00
Volume1,646,635
Avg. Volume2,006,882
Market Cap42.02B
Beta1.78
PE Ratio (TTM)112.96
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.26 (0.46%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Shire (SHPG) Rare Disease Drug Gets Fast Track Designation
    Zacksyesterday

    Shire (SHPG) Rare Disease Drug Gets Fast Track Designation

    Shire plc (SHPG) announced that the FDA has granted Fast Track designation for recombinant ADAMTS13 (SHP655) for the treatment of acute episodes of hereditary thrombotic thrombocytopenic purpura (hTTP).

  • Shire Plc breached its 50 day moving average in a Bearish Manner : SHP-GB : March 23, 2017
    Capital Cube2 days ago

    Shire Plc breached its 50 day moving average in a Bearish Manner : SHP-GB : March 23, 2017

    Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Shire Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Investopedia2 days ago

    Shire hTTP Drug Secures Fast Track Designation

    Shire is planning a late-stage study for its SHP655 drug to treat a rare enzyme deficiency.